Новости за 09.07.2024

14157/20 - Communicated Case

13816/22 - Communicated Case

28183/22 - Communicated Case

56889/17 - Communicated Case

47070/20 - Admissibility Decision

38059/12 - Committee Judgment

41418/23 - Communicated Case

41249/23 - Communicated Case

175/24 - Communicated Case

21714/22;25102/22;25367/22 - Admissibility Decision

22976/21 -

57272/19 -

54373/19 -

7011/19 -

21714/22;25102/22;25367/22 - Legal Summary

21714/22;25102/22;25367/22 - Legal Summary

18887/11 - Admissibility Decision

39627/16 -

21951/17 -

15972/20 -

19746/23 -

1400/22;18047/22;18056/22 -

15646/22;18440/22;19100/22;30054/22;31537/22;51056/22 -

42565/16 -

Targeted cell therapy helps some patients with intractable lymphoma, but those who relapse have few options. Stanford Medicine researchers found that modifying the molecular target significantly improved outcomes.